Lanean...
Safety Strategies of Genetically Engineered T Cells in Cancer Immunotherapy
T-cell therapy using genetically engineered T cells modified with either T cell receptor or chi-meric antigen receptor holds great promise for cancer immunotherapy. The concerns about its toxicities still remain despite recent successes in clinical trials. Temporal and spatial control of the enginee...
Gorde:
| Argitaratua izan da: | Curr Pharm Des |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Bentham Science Publishers
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5876919/ https://ncbi.nlm.nih.gov/pubmed/29283058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1381612824666171227222624 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|